Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease [Phase 2]
Phase 2 multicenter, double-blind, placebo-controlled safety and tolerability study of BMS-708163 in prodromal Alzheimer's disease was termi…
-
FDA approval · 2015-10-06FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for NAMZARIC (memantine hydrochloride and donepezil hydrochloride) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluated the cognitive and neurophysiological effects of raloxifene in Alzheimer's disease.
-
CLINICAL_TRIALS research · 2015-10-05Clinical Trial Update: Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
This completed clinical trial update describes an MRI study of posterior cingulate function in individuals at risk for Alzheimer's disease.
-
CLINICAL_TRIALS research · 2015-10-01Clinical Trial Update: Evaluation of Programs of Coordinated Care and Disease Management [NA]
This is a clinical trial update evaluating programs of coordinated care and disease management. The current status is unknown and multiple c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Yoga for Family Caregivers of Alzheimers Disease Patient [NA]
A completed clinical trial from the Federal University of São Paulo evaluated yoga for reducing stress and anxiety among family caregivers o…
-
CLINICAL_TRIALS research · 2015-09-30Clinical Trial Update: Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research [NA]
This study explored actigraphy and recognition video as tools to assess apathy in Alzheimer's disease; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Safety and Efficacy of MT-4666 [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of MT-4666 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Evaluation of Reader Training Processes [Phase 4]
Phase 4 study by Avid Radiopharmaceuticals evaluating reader training processes for Alzheimer's disease imaging completed; results posted in…
-
CLINICAL_TRIALS research · 2015-09-07Clinical Trial Update: Assessment of Social-emotional Functioning in Neurological Diseases [NA]
This clinical trial update notes the completion of a study evaluating social-emotional functioning in multiple neurological diseases. Diseas…
-
CLINICAL_TRIALS other · 2015-09-02Clinical Trial Update: Retrieval of Patient Information After Discontinuation
Clinical trial update for NCT01658722 in Alzheimer's disease noting termination and procedures for retrieving patient information after disc…
-
FDA approval · 2015-09-01FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Namzaric (memantine hydrochloride and donepezil hydrochloride) submitted by Allergan, Inc.
-
CLINICAL_TRIALS research · 2015-09-01Clinical Trial Update: Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project [NA]
A completed clinical trial evaluating a virtual reality–based intervention aimed at reducing apathy in Alzheimer's disease.
-
CLINICAL_TRIALS research · 2015-09-01Clinical Trial Update: Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease [NA]
This completed clinical trial evaluated the usability of virtual reality technology in people with mild cognitive impairment or Alzheimer's …
-
FDA approval · 2015-08-31FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for galantamine hydrobromide from Sun Pharmaceutical Industries, likely to update labeling or re…
-
CLINICAL_TRIALS withdrawal · 2015-08-24Clinical Trial Update: Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease [Phase 3]
This document reports the withdrawal of a Phase 3 pilot trial evaluating resveratrol supplementation in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Specific Care and Assistance Plan for Alzheimer's Disease [NA]
Completed clinical trial evaluating a Specific Care and Assistance Plan for Alzheimer's disease conducted by University Hospital, Toulouse.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient [NA]
The clinical trial evaluating physical training and cognitive activity in patients with Mild Cognitive Impairment and Alzheimer's disease ha…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects [Phase 1]
A completed Phase 1 study evaluated the effect of bexarotene on beta-amyloid and apolipoprotein E metabolism in healthy subjects.
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI [NA]
A clinical trial update from University Hospital, Caen, investigating the cerebral substrates of prospective memory across young adults, agi…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED) [Phase 1]
This completed Phase 1 study evaluated regional cerebral blood flow as a biomarker for Alzheimer's disease. It compared this biomarker to PE…
-
CLINICAL_TRIALS research · 2015-08-11Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease [NA]
Clinical trial update on transcranial direct current stimulation as a cognitive enhancer for Alzheimer's disease; current status of the tria…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia [Phase 1]
Phase 1 clinical trial evaluating whether anesthesia with propofol or isoflurane influences biomarkers associated with Alzheimer's disease; …
-
FDA approval · 2015-07-31FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves the original application for memantine hydrochloride (Upsher-Smith Laboratories) as a generic treatment for Alzheimer's disease…
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate? [NA]
This clinical trial update analyzes which features of a healing garden are used by people with Alzheimer's disease as landmarks to help them…